 |
eculizumab |
|---|---|
| Trade Name | Soliris |
| Orphan Indication | Neuromyelitis optica |
| USA Market Approval | USA |
| USA Designation Date | 2013-06-24 00:00:00 |
| Sponsor | Alexion Pharmaceuticals, Inc.;100 College Street;New Haven, Connecticut, 06510 |
| |
eculizumab |
|---|---|
| Trade Name | Soliris |
| Orphan Indication | Neuromyelitis optica |
| USA Market Approval | USA |
| USA Designation Date | 2013-06-24 00:00:00 |
| Sponsor | Alexion Pharmaceuticals, Inc.;100 College Street;New Haven, Connecticut, 06510 |